Sana Biotechnology, Inc. (SANA)
3.26
-0.03
(-0.91%)
USD |
NASDAQ |
Apr 27, 16:00
3.26
0.00 (0.00%)
After-Hours: 18:14
Sana Biotechnology Total Assets (Quarterly) : 426.72M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| ImmunityBio, Inc. | 501.90M |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Sarepta Therapeutics, Inc. | 3.350B |
| Beam Therapeutics, Inc. | 1.481B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 265.84M |
| Shareholders Equity (Quarterly) | 160.88M |
| Debt to Equity Ratio | 0.4902 |
| Current Ratio | 1.888 |
| Net Debt Paydown Yield | 0.32% |